The signs might be apparent in adults - but less noticeable in young infants. While RSV typically causes a mild, cold-like illness, it can also lead to severe illness such as bronchiolitis and ...

An American Samoa epidemiologist has extended the closure of daycare centres in the territory due to respiratory syncytial ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing ...

The adult population is a much bigger market for a potential RSV vaccine however, and accounts for the bulk of GSK's predictions of $4 billion in peak sales for its jab.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled ...

Participants were observed for two seasons, from August 31, 2021, to December 18, 2023, to evaluate vaccine efficacy, its safety and the increase in antibody levels against RSV-A and RSV-B variants.

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

Susie Barnes, SVP, head of global medical affairs, vaccines said: “As a leader in innovation and prevention, we are committed to collaborating with the global scientific community to better understand ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to protect adults aged 60 years and older against lower ...